Full-Year Revenue Growth (Excluding Confidential Contract)
Total revenue for fiscal year 2025 increased 12% year-over-year and was up 8% on an organic basis excluding the confidential contract; three-year total revenue increased 52% (CAGR ~10% organic; 9% CAGR excluding confidential).
Record Adjusted EBITDA and Margin Expansion
Fiscal 2025 adjusted EBITDA reached a record $609 million (up 1% vs. 2024) and adjusted EBITDA margin expanded 60 basis points to a company record of 9.6%; Q4 margin expanded 110 basis points to 9.6%.
Strong Free Cash Flow Conversion and Operating Cash Flow
Delivered 100% free cash flow conversion for fiscal 2025 and exceeded the high end of cash flow guidance; reported operating cash flow of $168 million in Q4, up 32% year-over-year.
Backlog, Funded Backlog and Pipeline Strength
Total backlog of $8.7 billion; funded backlog $6.4 billion (up 8% YoY) representing a company record 73% of total backlog. Management cites a $55 billion pipeline and $11 billion of awarded but not yet booked contracts.
Large Contract Wins and Booking Activity
Won 15 contracts >$100 million in the year (matching prior year). Notable Q4 awards: $392M 10-year biometric contract (booked $36M), $200M 5-year classified single-award (booked $23M), $125M 5-year HPC program (booked $44M), >$100M rocket motor manufacturing program (booked full). Post-quarter: FAA option exercised early ($593M) and intent to award up to $500M sole-source (booked $13M).
Critical Infrastructure Outperformance
Critical Infrastructure (CI) Q4 revenue up $89M (+12% YoY), organic growth 9%; CI adjusted EBITDA $87M in Q4 (up 87% YoY) with margin of 10.6% (up 420 bps). CI recorded 21 consecutive quarters with book-to-bill ≥1.0 and full-year CI adjusted EBITDA up 73% with margin expansion of 350 bps to 10.4%.
Disciplined Capital Deployment and Share Repurchases
Completed three acquisitions in 2025 (Applied Sciences among them) and increased share repurchases (Q4 repurchase ~856k shares for $60M; full year ~1.8M shares for $125M). Deployed over $1.1B on acquisitions, CapEx and buybacks since 2023 while maintaining a strong balance sheet.
Strategic M&A to Expand Capabilities
Closed Altamira acquisition post-quarter (all-cash transaction up to $375M incl. $45M earn-out) to expand signals intelligence, space, and multi‑intelligence capabilities; management emphasizes accretive acquisition strategy targeting >10% adjusted EBITDA margins.
Guidance and Long-Term Targets
2026 guidance: revenue $6.5–$6.8B (midpoint +4.5% YoY; +0.5% organic at midpoint with a disclosed $345M headwind from the confidential contract), adjusted EBITDA $615–$675M (midpoint margin ~9.7%), operating cash flow $470–$530M. Long-term targets reiterated: mid-single-digit+ organic growth, goal of double-digit margins by 2028, and ≥100% free cash conversion.